NCT04394481 Extension of Analgesia by Combined Injection of Dexamethasone and Dexmedetomidine After Arthroscopic Shoulder Surgery Status COMPLETED Phase PHASE4
NCT04392648 A Study to Evaluate the Safety, Tolerability and Efficacy of Intravenous TAK-573 as Part of Combination Therapy in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) Status WITHDRAWN Phase PHASE1
NCT04368598 The Combination of High-dose Dexamethasone and Acetylcysteine as the Treatment of Newly-diagnosed ITP Status UNKNOWN Phase PHASE2
NCT04355039 INCB053914 and Pomalidomide With Dexamethasone for Relapsed and/or Refractory Multiple Myeloma Status WITHDRAWN Phase PHASE1
NCT04353505 Intra-arterial Sphenopalatine Ganglion Block for Patients With Refractory Headache Status WITHDRAWN Phase PHASE1
NCT04352205 Daratumumab-Based Therapy for the Treatment of Newly Diagnosed Multiple Myeloma With Kidney Failure Status TERMINATED Phase PHASE2
NCT04346654 A Study to Assess Efficacy and Safety of Eltrombopag in Combination With a Short Course of Dexamethasone in Patients With Newly Diagnosed ITP Status COMPLETED Phase PHASE2
NCT04330690 Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial Status UNKNOWN Phase PHASE3
NCT04329650 Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID-19 Pneumonia Status COMPLETED Phase PHASE2
NCT04329325 Blinatumomab and Tyrosine Kinase Inhibitor Therapy in People With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04327401 COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III Status TERMINATED Phase PHASE3
NCT04325984 Role of Dexamethasone in Multimodal Analgesia for Postoperative Pain in Thoracic Surgery Status COMPLETED Phase N/A
NCT04325061 Efficacy of Dexamethasone Treatment for Patients With ARDS Caused by COVID-19 Status TERMINATED Phase PHASE4
NCT04320225 Connection Between Vitamin D Level and the Efficacy of Dexamethasone in Immune Thrombocytopenia Status UNKNOWN Phase N/A
NCT04308837 A Phase II Trial of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With Chemoradiation Status RECRUITING Phase PHASE2
NCT04302324 A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone (D-ClaPd) In Multiple Myeloma Patients Previously Exposed to Daratumumab Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04300556 A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types Status RECRUITING Phase PHASE1/PHASE2
NCT04287855 Multicenter Open Label Phase 2 Study of Isatuximab Plus Pomalidomide and Dexamethasone With Carfilzomib in Relapsed or Refractory Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE2